Global survey of dioxin- and thyroid hormone-like activities in consumer products and toys.

Background: Children and consumers are exposed to increasingly complex mixtures of known and as-yet-unknown toxic chemicals from toys and products. However traditional chemical analysis methods only evaluate a small number of chemicals at a time thereby restricting consumer awareness of the full range of potentially harmful chemicals in products.

Methods: We used high-throughput effect-based non-animal methods to investigate exposures to complex chemical mixtures of several kinds of brominated flame retardants (BFRs) for their dioxin- and thyroid hormone-like activities in various kinds of consumer products and toys from 26 different countries, on four continents (Africa, America, Asia and Europe) in combination with chemical analysis of various polybrominated flame retardants (BFRs) and their impurities (such as polyhalogenated PCDD/Fs and PBDD/Fs).

A global-scale assessment of fish mercury concentrations and the identification of biological hotspots.

We present data on a rapid assessment of fish Hg concentrations from 40 different waterbodies in 26 countries that includes data on 451 fish of 92 species. Significant differences in fish Hg concentrations were observed across fish foraging guilds and in general, higher trophic level fish (i.e.

Total lead concentration in new decorative enamel paints in Lebanon, Paraguay and Russia.

Lead concentrations in new enamel decorative paints were determined in three countries in different areas of the world where data were not previously available. The average total lead concentration of the enamel decorative paints purchased in Lebanon, Paraguay and Russia was 24,500ppm (ppm, dry weight), more than 270 times the current limit of 90ppm in Canada and in the United States. Sixty-three percent of these paints contained concentrations greater than 90ppm.

[Primary and secondary resistance to nicotine replacement therapy in tobacco dependent patients].

The terms of primary and secondary resistance to nicotine replacement therapy in tobacco dependent patients are defined. It is shown that treatment resistance is a result of a constellation of special clinical features of tobacco dependence, tolerance to nicotine, personality traits of the patients, family history of smoking, comorbid affective disorders and somatic diseases.